Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 10.28 Delayed Data As of Sep 24 |  -0.38 / -3.56%Today’s Change | 7.21 Today|||52-Week Range 16.37 | -18.41% Year-to-Date |
Latest ALPN News | Press Releases
No recent news for Alpine Immune Sciences Inc.
Today’s Trading
| Previous close | 10.66 |
| Today’s open | 10.88 |
| Day’s range | 10.28 - 10.94 |
| Volume | 2,751 |
| Average volume (3 months) | 122,393 |
| Market cap | $208.8M |
Data as of 4:14pm ET, 09/24/2021
Growth & Valuation
| Earnings growth (last year) | +41.15% |
| Earnings growth (this year) | +2.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +436.49% |
| P/E ratio | NM |
| Price/Sales | 28.11 |
| Price/Book | 3.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACETAdicet Bio Inc | +0.32 | +4.40% |
| KMDAKamada Ltd | +0.03 | +0.56% |
| HARPHarpoon Therapeutics... | -0.27 | -3.29% |
| AVROAVROBIO Inc | -0.28 | -4.48% |
Data as of 4:14pm ET, 09/24/2021
Financials
| Next reporting date | November 18, 2021 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $9.3M |
| Annual profit (last year) | -$27.9M |
| Net profit margin | -299.30% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
